Search

Objective: Stent restenosis (SR) is an important complication of percutaneous coronary intervention. There are many studies explored the relation of eosinophils with SR, however, there is no data about relationship between eosinophil- lymphocyte ratio (ELR) and SR. In this study we aimed to investigate the relationship between the value of ELR on admission and SR. Methods: The study was included 314 patients who had been applied a coronary stent implantation and they were admitted to cardiology clinic with stabile angina and underwent repeat coronary angiography. The data obtained from patients were analyzed retrospectively. The patient group was consisted of 197 patients who were diagnosed as SR, and the control group was consisted of 117 patients whose stents were patent angiographically. Results: The groups were similar in terms of age, gender, hypertension, diabetes mellitus, LDL-C, HDL-C, platelet count, platelet-lymphocyte ratio (PLR), hemoglobin and left ventricle ejection fraction (LVEF). White blood cell (WBC), neutrophil, eosinophil, C-reactive protein (CRP), ELR and neutrophil-lymphocyte ratio (NLR) on admission were higher in the SR group compared to the controls. All patients were categorized into two groups according to ELR values and SR was more frequent in the high ELR group compared to low ELR group. An ELR value of =0.745 predicted SR with 64% sensitivity and 61% specifity. Conclusion: In this study ELR was found statistically higher in SR patients compared to the controls. According to our data ELR as an inexpensive and easy method, may contribute to determination of high risk patients and increased ELR can be used as a predictor of SR. [ABSTRACT FROM AUTHOR]

Objectives: In this study, we aimed to compare the effects of infarct localization in patients with ST Elevated Myocardial Infarction (STEMI) on the right ventricular (RV) functions by using advanced echocardiographic methods. Materials and methods: A total of 89 patients with STEMI were included into the study and patients were divided to three groups as anterior, isolated-inferior and inferior+RV MI groups. In addition to standard echocardiographic mesurements, RV tissue doppler, RV Ejection Fraction (RVEF), Myocardial performance index (MPI) and TAPSE measurements of all patients were performed between 24-72 hours after the event. Results: Compared to groups, RV functions in inferior MI with RV involvement group were deteriorated. Tricuspid annular plane systolic excursion (TAPSE) value for the inferior MI with RV involvement (19±1mm) group were lower than those for Inferior MI group without RV involvement (23±1mm) and anterior MI (23±1mm) (p<0.05). The RV MPI value for inferior MI group with RV involvement (0.76±0.14) were found to be higher than those for anterior (0.64±0.1) and inferior MI (0.56±0.1) group without RV involvement (p<0.05). Peak Sm (r = -0.35, p = 0.01), TAPSE (r = -0.47, p<0.001) and RV EF (r = -0.46, p<0.001) showed a negative correlation with RV MPI value. Furthermore, RV tricuspid E/A rate (r = -0.19, p = 0.7) and RV free wall tissue doppler Em/Am rate (r = -0.26, p = 0.01) displayed a negative correlation with RV MPI value. Conclusions: Use of advanced methods addition to the conventional echocardiographic methods in STEMI patients, could produce more valuable information to evaluate RV functions and provide a positive impact on treatment strategies. [ABSTRACT FROM AUTHOR]

Objective: In this study, we aimed to present the characteristics and short-term clinical outcomes of the patients admitted to our clinic with a diagnosis of carotid artery disease and revascularized by carotid artery stenting (CAS). Methods: The study was retrospective and a singlecentered study. Between May 2012 and May 2014 the patients with an indication for carotid artery intervention and accepted CAS procedure were included in the study. Clinical characteristics and procedural data of the patients were obtained by scanning patient files. After discharge, hospital records were scanned and patients were called to learn whether or not patients were alive and that they have suffered a recent stroke. Results: We included 26 patients that meet the inclusion criteria in the study. 69% of patients were female with a mean age of 66 ± 9 years. 73% of patients were symptomatic, 73% had hypertension, 27% had diabetes mellitus, 39% had hyperlipidemia, 69% had coronary artery disease and 31% were active smoker. In all patients, selfexpandable stents and distal embolic protection devices were used. 18 left, six right, and two bilateral (in separate sessions) carotid arteries were stented with a total of 26 patients and 28 successful CAS. Due to residual stenosis a second stent was implanted only in one patient. One patient experienced a partial muscle weakening in upper extremity due to an air embolism, which recovered spontaneously in 24 hours. Patients were followed for 11.5 ± 8 (minimum 2-maximum 27, median 10) months. During follow-up, no patients had recurrent stroke and transischemic attack. One patient died after eight months of CAS. Conclusion: CAS is being successfully applied with a very low risk of complications in experienced centers. Short-term clinical results of CAS are quite satisfactory. [ABSTRACT FROM AUTHOR]

Objective: In this study, we aimed to evaluate the characteristic of patients with supraventricular tachycardia for proper diagnosis and treatment in Southeast Anatolian region. Methods: The study was has a retrospective cross-sectional design. One hundred eighty-seven consecutive patients who underwent catheter ablation of SVT between June 2012 and April 2014 at the Dicle University Heart Hospital were included in the study. In those patients, in whom the arrhythmia substrate was identified, ablation therapy was carried out using radiofrequency (RF) energy. Results: Among SVTs 119 (63.6%) patients had atrioventricular nodal re-entry tachycardia (AVNRT), 20 (10.7%) patients had concealed atrioventricular re-entry tachycardia (AVRT), 40 (21.4%) patients had Wolf Parkinson White (WPW) syndrome, and 8 (4.3%) patients had atrial tachycardia. RF ablation was applied on 184 patients. Overall RF ablation success rate was 96.2%. Overall recurrence was 8 (4%) of 187 patients during the followup period 12 ± 6 (1-23) months. The recurrence was 4 (3.4%) of 119 patients in AVNRT, 2(5%) of 40 patients in WPW syndrome and 2 (10%) of 20 patients in concealed AVRT. There was no statistically significant difference between groups in terms of recurrence. Two patients having AVNRT ablation died due to acute coronary syndrome in clinical follow-up. Conclusion: The acute and long-term success rates of SVT ablation were in accordance with literature. The other characteristics of SVT were similar with the current data. [ABSTRACT FROM AUTHOR]

Objective: We sought to evaluate our clinical experience and short-term results of percutaneous closure of patent ductus arteriosus (PDA). Methods: We studied 20 patients (17 female, mean age 24±8 years) undergoing percutaneous closure of PDA between March 2010-March 2013 in our clinic. Amplatzer duct occluder (ADO) I was used in 13 patients and ADO II was used in 7 patients for PDA closure. Clinical characteristics of patients, properties of percutaneous closure intervention, complications and short-term results are evaluated. Results: The mean ductus waist diameter measured by angiographic examination was 5±2 mm (2-9 mm). Procedure was successfully performed in all patients. Occluder device embolization was occurred in one patient in whom device was retrieved by snare catheter and PDA was successfully closed with same device. The early total occlusion rate was 85%. Occlusion rate as determined by echocardiographic control performed the day after was 95% whereas 100% at first month. In the follow-up of 19±9 months, no complications were observed. Conclusion: Percutaneous closure of PDA using ADO I and II devices are safe and effective. [ABSTRACT FROM AUTHOR]